A composition for treating cancer comprising an anti-tumorally effective amount of a product comprising at least one transduction inhibitor of heterotrimeric G protein signals and at least one other anti-cancer agent selected from the group consisting of prenyltransferase inhibitors, taxol and its analogues, gemcitabine and camptothecin and its analogues, administered simultaneously, separately or spread over a period of time and a pharmaceutical carrier.

 
Web www.patentalert.com

< N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof

< Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions

> 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

> Method of treating post operative nausea and vomiting
~ 00251